Decoded
From Mars Rovers to Medicine: The AI Revolution with Thomas Fuchs, Chief AI Officer, Eli Lilly
29:53
What happens when the mind behind the Mars Rovers turns its attention to fighting cancer and developing next-generation medicines? Today, Thomas Fuchs is the Chief AI Officer at Eli Lilly & Company, but he started his career at NASA, building the AI that helped rovers navigate the surface of Mars. He soon realized that the same math used to distinguish sand from rocks could be used to identify…